Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Giorgio V. Scagliotti, Rabab Mohamed Gaafar, Anna K. Nowak et al. · The Lancet Respiratory Medicine · 2019

Cited by 168 works. doi:10.1016/s2213-2600(19)30139-0

Authors

References